All Stories

  1. The 6-Aminoquinolone WC5 Inhibits Different Functions of the Immediate-Early 2 (IE2) Protein of Human Cytomegalovirus That Are Essential for Viral Replication
  2. Ethyl 1,8-Naphthyridone-3-carboxylates Downregulate Human Papillomavirus-16 E6 and E7 Oncogene Expression
  3. Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds
  4. Antiviral strategies against influenza virus: towards new therapeutic approaches
  5. Approaches for the Generation of New Anti-cytomegalovirus Agents: Identification of Protein–Protein Interaction Inhibitors and Compounds Against the HCMV IE2 Protein
  6. Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly
  7. Regulated Transport into the Nucleus of Herpesviridae DNA Replication Core Proteins
  8. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions
  9. Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Human Cytomegalovirus Immediate‐Early 2 Protein, a Promising Target for Anti‐HCMV Treatment
  10. How academic labs can approach the drug discovery process as a way to synergize with big pharma
  11. The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Is Modified by SUMO in a DNA-Dependent Manner
  12. Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses
  13. Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients
  14. Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives
  15. Multiple phosphorylation sites at the C-terminus regulate nuclear import of HCMV DNA polymerase processivity factor ppUL44
  16. Strategies and Methods in Monitoring and Targeting Protein–Protein Interactions
  17. Human cytomegalovirus DNA replication: antiviral targets and drugs
  18. A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity
  19. Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection
  20. Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection
  21. Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses
  22. Cloning, Expression, and Functional Characterization of the Equine Herpesvirus 1 DNA Polymerase and Its Accessory Subunit
  23. Selective Anti-Cytomegalovirus Compounds Discovered by Screening for Inhibitors of Subunit Interactions of the Viral Polymerase
  24. Disruption of the interactions between the subunits of herpesvirus DNA polymerases as a novel antiviral strategy
  25. Disruption of protein–protein interactions: Towards new targets for chemotherapy
  26. Strategies and Methods in Monitoring and Targeting Protein–Protein Interactions
  27. The Cytomegalovirus DNA Polymerase Subunit UL44 Forms a C Clamp-Shaped Dimer
  28. pH-Dependent Conformational Changes and Topology of a Herpesvirus Translocating Peptide in a Membrane-Mimetic Environment
  29. Inhibition of Human Cytomegalovirus DNA Polymerase by C-Terminal Peptides from the UL54 Subunit
  30. The Sp1 transcription factor does not directly interact with the HIV‐1 Tat protein
  31. Interaction of Sp1 transcription factor with HIV‐1 Tat protein: looking for cellular partners
  32. Protein–protein interactions as targets for antiviral chemotherapy
  33. Separation methods for acyclovir and related antiviral compounds
  34. Analysis of the antigen specific T cell repertoires in HIV infection
  35. The Catalytic Subunit of Herpes Simplex Virus Type 1 DNA Polymerase Contains a Nuclear Localization Signal in the UL42-Binding Region
  36. Use ofVibriospp. for Expression ofEscherichia coliEnterotoxin B Subunit Fusion Proteins: Purification and Characterization of a Chimera Containing a C-Terminal Fragment of DNA Polymerase from Herpes Simplex Virus Type 1
  37. Identification and characterization of an extracellular protease activity produced by the marine Vibriosp 60
  38. Peptide disruption of protein-protein complexes: a novel strategy for antiviral therapy
  39. Quantitative Analysis of Ribonucleotide Triphosphates in Cell Extracts by High-Performance Liquid Chromatography and Micellar Electrokinetic Capillary Chromatography: A Comparative Study
  40. Efficient extracellular production of hybridE. coliheat-labile enterotoxin B subunits in a marine vibrio
  41. Effect of neutral and acidic phospholipids on mitochondrial ATP synthase secondary structure